test-time-scaling
(2)
Nabla Bio
Nabla Bio is a Cambridge, Massachusetts biotech building AI plus wet-lab technology to design antibodies and protein therapeutics from scratch. Its Joint Atomic Modeling (JAM) platform generates de novo binders against historically undruggable membrane proteins like GPCRs, and the company has signed collaborations with AstraZeneca, Bristol Myers Squibb, and Takeda worth over a billion dollars in potential payments.
Azalia Mirhoseini
Azalia Mirhoseini is an Iranian-born AI researcher, Stanford professor, and co-founder of Ricursive Intelligence - a frontier AI lab valued at $4 billion that uses AI to design better chips, which in turn train stronger AI. Best known for AlphaChip, the deep reinforcement learning system that now designs Google's TPUs and has compressed chip floorplanning from months to hours, she also co-invented the Mixture-of-Experts architecture underpinning GPT, Claude, and Gemini. With 20,000+ citations and a $335M-funded startup launched in under four months, she is closing the recursive loop between artificial intelligence and the hardware it runs on.